{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:52:03Z","timestamp":1781823123456,"version":"3.54.5"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12033-026-01561-6","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:31:21Z","timestamp":1773397881000},"page":"3032-3050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Oncoviruses in Cancer Progression and Emerging Phytochemical-Based Therapies from Medicinal Plants"],"prefix":"10.1007","volume":"68","author":[{"given":"Shivani","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-8258","authenticated-orcid":false,"given":"Pardeep","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"1561_CR1","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1002\/jcb.26717","volume":"119","author":"J Cao","year":"2018","unstructured":"Cao, J., & Li, D. (2018). Searching for human oncoviruses: Histories, challenges, and opportunities. Journal of Cellular Biochemistry, 119, 4897\u20134906. https:\/\/doi.org\/10.1002\/jcb.26717","journal-title":"Journal of Cellular Biochemistry"},{"key":"1561_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","volume":"15","author":"EA Mesri","year":"2014","unstructured":"Mesri, E. A., Feitelson, M. A., & Munger, K. (2014). Human viral oncogenesis: A cancer hallmarks analysis. Cell Host & Microbe, 15, 266\u2013282. https:\/\/doi.org\/10.1016\/j.chom.2014.02.011","journal-title":"Cell Host & Microbe"},{"key":"1561_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/v16030416","volume":"16","author":"L Galati","year":"2024","unstructured":"Galati, L., Chiantore, M. V., Marinaro, M., & Di Bonito, P. (2024). Human oncogenic viruses: Characteristics and prevention strategies\u2014Lessons learned from human papillomaviruses. Viruses, 16, Article 416. https:\/\/doi.org\/10.3390\/v16030416","journal-title":"Viruses"},{"key":"1561_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2024.200289","volume":"18","author":"BT Guzha","year":"2024","unstructured":"Guzha, B. T., Matubu, A., Nyandoro, G., Mubata, H. O., Moyo, E., Murewanhema, G., et al. (2024). The impact of DNA tumor viruses in low-to-middle income countries (LMICS): A literature review. Tumour Virus Research, 18, Article 200289. https:\/\/doi.org\/10.1016\/j.tvr.2024.200289","journal-title":"Tumour Virus Research"},{"key":"1561_CR5","volume-title":"StatPearls","author":"L Luria","year":"2025","unstructured":"Luria, L., & Cardoza-Favarato, G. (2025). Human Papillomavirus. StatPearls. StatPearls Publishing."},{"issue":"11","key":"1561_CR6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2400517121","volume":"121","author":"DR Lowy","year":"2024","unstructured":"Lowy, D. R. (2024). Harald zur Hausen (1936 to 2023): Discoverer of human papillomavirus infection as the main cause of cervical cancer. Proceedings of the National Academy of Sciences, 121(11), Article e2400517121. https:\/\/doi.org\/10.1073\/pnas.2400517121","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1561_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6120111","volume":"6","author":"U Mui","year":"2017","unstructured":"Mui, U., Haley, C., & Tyring, S. (2017). Viral oncology: Molecular biology and pathogenesis. Journal of Clinical Medicine, 6, Article 111. https:\/\/doi.org\/10.3390\/jcm6120111","journal-title":"Journal of Clinical Medicine"},{"key":"1561_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-025-02197-9","volume":"10","author":"Q Xiao","year":"2025","unstructured":"Xiao, Q., Liu, Y., Li, T., Wang, C., He, S., Zhai, L., et al. (2025). Viral oncogenesis in cancer: From mechanisms to therapeutics. Signal Transduction and Targeted Therapy, 10, 151. https:\/\/doi.org\/10.1038\/s41392-025-02197-9","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1561_CR9","unstructured":"Gallo, R. C., and Marvin S. Reitz, J. (2003). Mechanisms of Oncogenesis. In Holland-Frei Cancer Medicine. 6th edition. BC Decker. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK13042\/"},{"key":"1561_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071082","author":"SR Singh","year":"2025","unstructured":"Singh, S. R., Bhaskar, R., Ghosh, S., Yarlagadda, B., Singh, K. K., Verma, P., et al. (2025). Exploring the genetic orchestra of cancer: The interplay between oncogenes and tumor-suppressor genes. Cancers. https:\/\/doi.org\/10.3390\/cancers17071082","journal-title":"Cancers"},{"key":"1561_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10070213","volume":"10","author":"ML Tornesello","year":"2018","unstructured":"Tornesello, M. L., Annunziata, C., Tornesello, A. L., Buonaguro, L., & Buonaguro, F. M. (2018). Human oncoviruses and p53 tumor suppressor pathway deregulation at the origin of human cancers. Cancers, 10, Article 213. https:\/\/doi.org\/10.3390\/cancers10070213","journal-title":"Cancers"},{"key":"1561_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.48022\/mbl.2303.03006","volume":"51","author":"ZU Abedien","year":"2023","unstructured":"Abedien, Z. U., Gul, K., Khan, S., Shafiq, M., Rahman, K., & Nawaz, M. H. (2023). Pathogenesis of oncoviruses: A systemic review. Microbiology and Biotechnology Letters, 51, 135\u2013146. https:\/\/doi.org\/10.48022\/mbl.2303.03006","journal-title":"Microbiology and Biotechnology Letters"},{"key":"1561_CR13","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ypmed.2011.08.017","volume":"53","author":"JE Tota","year":"2011","unstructured":"Tota, J. E., Chevarie-Davis, M., Richardson, L. A., deVries, M., & Franco, E. L. (2011). Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Preventive Medicine, 53, S12\u2013S21. https:\/\/doi.org\/10.1016\/j.ypmed.2011.08.017","journal-title":"Preventive Medicine"},{"key":"1561_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11121510","volume":"11","author":"E Kudela","year":"2022","unstructured":"Kudela, E., Kudelova, E., Kozub\u00edk, E., Rokos, T., Pribulova, T., Holubekova, V., et al. (2022). HPV-associated breast cancer: Myth or fact? Pathogens, 11, Article 1510. https:\/\/doi.org\/10.3390\/pathogens11121510","journal-title":"Pathogens"},{"key":"1561_CR15","first-page":"299","volume":"34","author":"S Elrefaey","year":"2014","unstructured":"Elrefaey, S., Massaro, M. A., Chiocca, S., Chiesa, F., & Ansarin, M. (2014). HPV in oropharyngeal cancer: The basics to know in clinical practice. Acta Otorhinolaryngologica Italica, 34, 299\u2013309.","journal-title":"Acta Otorhinolaryngologica Italica"},{"key":"1561_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.31481","volume":"73","author":"KJ Wangensteen","year":"2021","unstructured":"Wangensteen, K. J., & Chang, K. (2021). Multiple roles for Hepatitis B and C viruses and the host in the development of hepatocellular carcinoma. Hepatology, 73, 27\u201337. https:\/\/doi.org\/10.1002\/hep.31481","journal-title":"Hepatology"},{"key":"1561_CR17","doi-asserted-by":"publisher","DOI":"10.18502\/ijhoscr.v17i2.12650","author":"A Agolli","year":"2023","unstructured":"Agolli, A., Ishak, A., Viswanathan, M., Lorraine, E., Shivakumar, J., & Agolli, O. (2023). Epstein-Barr viral infection and the risk for breast cancer: a systematic review. International Journal of Hematology-Oncology and Stem Cell Research. https:\/\/doi.org\/10.18502\/ijhoscr.v17i2.12650","journal-title":"International Journal of Hematology-Oncology and Stem Cell Research"},{"key":"1561_CR18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019332","author":"CRM Bangham","year":"2023","unstructured":"Bangham, C. R. M. (2023). HTLV-1 persistence and the oncogenesis of adult T cell leukemia\/lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood.2022019332","journal-title":"Blood"},{"key":"1561_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc2888","volume":"10","author":"EA Mesri","year":"2010","unstructured":"Mesri, E. A., Cesarman, E., & Boshoff, C. (2010). Kaposi\u2019s sarcoma and its associated herpesvirus. Nature Reviews Cancer, 10, 707\u2013719. https:\/\/doi.org\/10.1038\/nrc2888","journal-title":"Nature Reviews Cancer"},{"key":"1561_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3389\/fonc.2019.01236","volume":"9","author":"E Guven-Maiorov","year":"2019","unstructured":"Guven-Maiorov, E., Tsai, C.-J., & Nussinov, R. (2019). Oncoviruses can drive cancer by rewiring signaling pathways through interface mimicry. Frontiers Oncology, 9, 1236. https:\/\/doi.org\/10.3389\/fonc.2019.01236","journal-title":"Frontiers Oncology"},{"key":"1561_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1280210","volume":"14","author":"J Minarovits","year":"2023","unstructured":"Minarovits, J. (2023). Human tumor viruses: Induction of three-dimensional alterations in the host genome structure. Frontiers in Microbiology, 14, Article 1280210. https:\/\/doi.org\/10.3389\/fmicb.2023.1280210","journal-title":"Frontiers in Microbiology"},{"key":"1561_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","volume":"148","author":"Y Wong","year":"2022","unstructured":"Wong, Y., Meehan, M. T., Burrows, S. R., Doolan, D. L., & Miles, J. J. (2022). Estimating the global burden of Epstein\u2013Barr virus-related cancers. Journal of Cancer Research and Clinical Oncology, 148, 31\u201346. https:\/\/doi.org\/10.1007\/s00432-021-03824-y","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"1561_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/s0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964). Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet, 1, 702\u2013703. https:\/\/doi.org\/10.1016\/s0140-6736(64)91524-7","journal-title":"Lancet"},{"key":"1561_CR24","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1016\/j.vaccine.2019.04.071","volume":"37","author":"DH Mulama","year":"2019","unstructured":"Mulama, D. H., Mutsvunguma, L. Z., Totonchy, J., Ye, P., Foley, J., Escalante, G. M., et al. (2019). A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits. Vaccine, 37, 4184\u20134194. https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.071","journal-title":"Vaccine"},{"key":"1561_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1561_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.virol.2009.07.002","volume":"392","author":"V Bottero","year":"2009","unstructured":"Bottero, V., Sharma-Walia, N., Kerur, N., Paul, A. G., Sadagopan, S., Cannon, M., et al. (2009). Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: A potential positive feedback loop for sustained ORF50 gene expression. Virology, 392, 34\u201351. https:\/\/doi.org\/10.1016\/j.virol.2009.07.002","journal-title":"Virology"},{"key":"1561_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3181\/00379727-72-17328","volume":"72","author":"MJ Strauss","year":"1949","unstructured":"Strauss, M. J., Shaw, E. W., Bunting, H., & Melnick, J. L. (1949). \u201cCrystalline\u201d virus-like particles from skin papillomas characterized by intranuclear inclusion bodies. Experimental Biology and Medicine, 72, 46\u201350. https:\/\/doi.org\/10.3181\/00379727-72-17328","journal-title":"Experimental Biology and Medicine"},{"key":"1561_CR28","unstructured":"Cervical Cancer Elimination Initiative. (n.d.). Retrieved January 25, 2026, from https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative"},{"key":"1561_CR29","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.1152586","volume":"319","author":"H Feng","year":"2008","unstructured":"Feng, H., Shuda, M., Chang, Y., & Moore, P. S. (2008). Clonal integration of a polyomavirus in human Merkel Cell Carcinoma. Science, 319, 1096\u20131100. https:\/\/doi.org\/10.1126\/science.1152586","journal-title":"Science"},{"key":"1561_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246176","volume":"14","author":"S Silling","year":"2022","unstructured":"Silling, S., Kreuter, A., Gambichler, T., Meyer, T., Stockfleth, E., & Wieland, U. (2022). Epidemiology of Merkel Cell Polyomavirus infection and Merkel Cell Carcinoma. Cancers, 14, Article 6176. https:\/\/doi.org\/10.3390\/cancers14246176","journal-title":"Cancers"},{"key":"1561_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225548","volume":"14","author":"MG Dimitraki","year":"2022","unstructured":"Dimitraki, M. G., & Sourvinos, G. (2022). Merkel Cell Polyomavirus (MCPyV) and cancers: Emergency bell or false alarm? Cancers, 14, Article 5548. https:\/\/doi.org\/10.3390\/cancers14225548","journal-title":"Cancers"},{"key":"1561_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1126\/science.325649","volume":"197","author":"BS Blumberg","year":"1977","unstructured":"Blumberg, B. S. (1977). Australia Antigen and the biology of Hepatitis B. Science, 197, 17\u201325. https:\/\/doi.org\/10.1126\/science.325649","journal-title":"Science"},{"key":"1561_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","volume":"20","author":"NP Nelson","year":"2016","unstructured":"Nelson, N. P., Easterbrook, P. J., & McMahon, B. J. (2016). Epidemiology of Hepatitis B Virus infection and impact of vaccination on disease. Clinics in Liver Disease, 20, 607\u2013628. https:\/\/doi.org\/10.1016\/j.cld.2016.06.006","journal-title":"Clinics in Liver Disease"},{"key":"1561_CR34","unstructured":"Hepatitis B. (n.d.). Retrieved January 25, 2026, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"key":"1561_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/294268a0","volume":"294","author":"BJ Poiesz","year":"1981","unstructured":"Poiesz, B. J., Ruscetti, F. W., Reitz, M. S., Kalyanaraman, V. S., & Gallo, R. C. (1981). Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with S\u00e9zary T-cell leukaemia. Nature, 294, 268\u2013271. https:\/\/doi.org\/10.1038\/294268a0","journal-title":"Nature"},{"key":"1561_CR36","doi-asserted-by":"publisher","first-page":"11685","DOI":"10.1073\/pnas.1920346117","volume":"117","author":"M Nagasaka","year":"2020","unstructured":"Nagasaka, M., Yamagishi, M., Yagishita, N., Araya, N., Kobayashi, S., Makiyama, J., et al. (2020). Mortality and risk of progression to adult T cell leukemia\/lymphoma in HTLV-1\u2013associated myelopathy\/tropical spastic paraparesis. Proceedings of the National Academy of Sciences of the United States of America, 117, 11685\u201311691. https:\/\/doi.org\/10.1073\/pnas.1920346117","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"1561_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01925.x","volume":"29","author":"M Houghton","year":"2009","unstructured":"Houghton, M. (2009). Discovery of the Hepatitis C virus. Liver International, 29, 82\u201388. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01925.x","journal-title":"Liver International"},{"key":"1561_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2025.100940","volume":"57","author":"P Balakrishnan","year":"2025","unstructured":"Balakrishnan, P., Saravanan, S., Vignesh, R., Sivamalar, S., Nallusamy, D., Sankar, S., et al. (2025). Discovery of HCV vaccine: Where do we stand? Indian Journal of Medical Microbiology, 57, Article 100940. https:\/\/doi.org\/10.1016\/j.ijmmb.2025.100940","journal-title":"Indian Journal of Medical Microbiology"},{"key":"1561_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coviro.2018.08.014","volume":"32","author":"O Manners","year":"2018","unstructured":"Manners, O., Murphy, J. C., Coleman, A., Hughes, D. J., & Whitehouse, A. (2018). Contribution of the KSHV and EBV lytic cycles to tumourigenesis. Current Opinion in Virology, 32, 60\u201370. https:\/\/doi.org\/10.1016\/j.coviro.2018.08.014","journal-title":"Current Opinion in Virology"},{"key":"1561_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-642-27340-7_7","volume":"369","author":"V Lohmann","year":"2013","unstructured":"Lohmann, V. (2013). Hepatitis C Virus RNA replication. Hepatitis C Virus Molecular Virology and Antiviral Therapy, 369, 167\u2013198. https:\/\/doi.org\/10.1007\/978-3-642-27340-7_7","journal-title":"Hepatitis C Virus Molecular Virology and Antiviral Therapy"},{"key":"1561_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00247","volume":"3","author":"T Zhao","year":"2012","unstructured":"Zhao, T., & Matsuoka, M. (2012). HBZ and its roles in HTLV-1 oncogenesis. Frontiers in Microbiology, 3, Article 247. https:\/\/doi.org\/10.3389\/fmicb.2012.00247","journal-title":"Frontiers in Microbiology"},{"key":"1561_CR42","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.molmed.2024.05.009","volume":"30","author":"MA Molina","year":"2024","unstructured":"Molina, M. A., Steenbergen, R. D. M., Pumpe, A., Kenyon, A. N., & Melchers, W. J. G. (2024). HPV integration and cervical cancer: A failed evolutionary viral trait. Trends in Molecular Medicine, 30, 890\u2013902. https:\/\/doi.org\/10.1016\/j.molmed.2024.05.009","journal-title":"Trends in Molecular Medicine"},{"key":"1561_CR43","unstructured":"Humans, I. W. G. on the E. of C. R. to. (2007). Human Papillomavirus (HPV) Infection. In Human Papillomaviruses. International Agency for Research on Cancer. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK321770\/"},{"key":"1561_CR44","unstructured":"HPV and Cancer - NCI. (2019, March 1). cgvArticle. Retrieved January 25, 2026, from https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-and-cancer"},{"key":"1561_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02083-w","volume":"10","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Qiu, K., Ren, J., Zhao, Y., & Cheng, P. (2025). Roles of human papillomavirus in cancers: Oncogenic mechanisms and clinical use. S Signal Transduction and Targeted Therapy, 10, Article 44. https:\/\/doi.org\/10.1038\/s41392-024-02083-w","journal-title":"S Signal Transduction and Targeted Therapy"},{"key":"1561_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00674-20","volume":"94","author":"A Piirsoo","year":"2020","unstructured":"Piirsoo, A., Kala, M., Sankovski, E., Ustav, M., & Piirsoo, M. (2020). Uncovering the role of the E1 protein in different stages of Human Papillomavirus 18 genome replication. Journal of Virology, 94, Article e00674-20. https:\/\/doi.org\/10.1128\/JVI.00674-20","journal-title":"Journal of Virology"},{"key":"1561_CR47","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1128\/JVI.74.8.3752-3760.2000","volume":"74","author":"A Nishimura","year":"2000","unstructured":"Nishimura, A., Ono, T., Ishimoto, A., Dowhanick, J. J., Frizzell, M. A., Howley, P. M., et al. (2000). Mechanisms of Human Papillomavirus E2-mediated repression of viral oncogene expression and Cervical Cancer cell growth inhibition. Journal of Virology, 74, 3752\u20133760. https:\/\/doi.org\/10.1128\/JVI.74.8.3752-3760.2000","journal-title":"Journal of Virology"},{"key":"1561_CR48","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s13337-022-00786-8","volume":"33","author":"D Balaji","year":"2022","unstructured":"Balaji, D., Kalarani, I. B., Mohammed, V., & Veerabathiran, R. (2022). Potential role of human papillomavirus proteins associated with the development of cancer. VirusDisease, 33, 322\u2013333. https:\/\/doi.org\/10.1007\/s13337-022-00786-8","journal-title":"VirusDisease"},{"key":"1561_CR49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/0300060513506655","volume":"42","author":"Z Lou","year":"2014","unstructured":"Lou, Z., & Wang, S. (2014). E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis. Journal of International Medical Research, 42, 247\u2013260. https:\/\/doi.org\/10.1177\/0300060513506655","journal-title":"Journal of International Medical Research"},{"key":"1561_CR50","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2017.18.2.315","author":"AI Yajid","year":"2017","unstructured":"Yajid, A. I., Zakariah, M. A., Mat Zin, A. A., & Othman, N. H. (2017). Potential role of E4 protein in Human Papillomavirus screening: A review. Asian Pacific Journal of Cancer Prevention. https:\/\/doi.org\/10.22034\/APJCP.2017.18.2.315","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"1561_CR51","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1038\/s41388-020-01431-8","volume":"39","author":"S Ren","year":"2020","unstructured":"Ren, S., Gaykalova, D. A., Guo, T., Favorov, A. V., Fertig, E. J., Tamayo, P., et al. (2020). HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers. Oncogene, 39, 6327\u20136339. https:\/\/doi.org\/10.1038\/s41388-020-01431-8","journal-title":"Oncogene"},{"key":"1561_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000214918","volume":"12","author":"M Lehoux","year":"2009","unstructured":"Lehoux, M., D\u2019Abramo, C. M., & Archambault, J. (2009). Molecular mechanisms of Human Papillomavirus-induced carcinogenesis. Public Health Genomics, 12, 268\u2013280. https:\/\/doi.org\/10.1159\/000214918","journal-title":"Public Health Genomics"},{"key":"1561_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41417-023-00682-3","volume":"31","author":"Q Peng","year":"2024","unstructured":"Peng, Q., Wang, L., Zuo, L., Gao, S., Jiang, X., Han, Y., et al. (2024). HPV E6\/E7: Insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor. Cancer Gene Therapy, 31, 9\u201317. https:\/\/doi.org\/10.1038\/s41417-023-00682-3","journal-title":"Cancer Gene Therapy"},{"key":"1561_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2025.200313","volume":"19","author":"Y Chen","year":"2025","unstructured":"Chen, Y., Egawa, N., Zheng, K., & Doorbar, J. (2025). How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infection. Tumour Virus Research, 19, Article 200313. https:\/\/doi.org\/10.1016\/j.tvr.2025.200313","journal-title":"Tumour Virus Research"},{"key":"1561_CR55","unstructured":"Humans, I. W. G. on the E. of C. R. to. (2012). Epstein-Barr Virus. In Biological Agents. International Agency for Research on Cancer. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK304353\/"},{"key":"1561_CR56","unstructured":"Epstein-Barr Virus (EBV) - Symptoms, Causes and Treatment. (n.d.). Cleveland Clinic. Retrieved January 25, 2026, from https:\/\/my.clevelandclinic.org\/health\/diseases\/23469-epstein-barr-virus"},{"key":"1561_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00457","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee, S., Ghosh Roy, S., Bose, P., & Saha, A. (2016). Role of EBNA-3 family proteins in EBV associated B-cell lymphomagenesis. Frontiers in Microbiology. https:\/\/doi.org\/10.3389\/fmicb.2016.00457","journal-title":"Frontiers in Microbiology"},{"key":"1561_CR58","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1128\/JVI.00013-12","volume":"86","author":"N Sivachandran","year":"2012","unstructured":"Sivachandran, N., Wang, X., & Frappier, L. (2012). Functions of the Epstein-Barr Virus EBNA1 protein in viral reactivation and lytic infection. Journal of Virology, 86, 6146\u20136158. https:\/\/doi.org\/10.1128\/JVI.00013-12","journal-title":"Journal of Virology"},{"key":"1561_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02501-7","volume":"4","author":"Y Yang","year":"2021","unstructured":"Yang, Y., Ye, X., Dai, R., Li, Z., Zhang, Y., Xue, W., et al. (2021). Phase separation of Epstein-Barr virus EBNA2 protein reorganizes chromatin topology for epigenetic regulation. Communications Biology, 4, Article 967. https:\/\/doi.org\/10.1038\/s42003-021-02501-7","journal-title":"Communications Biology"},{"key":"1561_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens7010031","volume":"7","author":"C Styles","year":"2018","unstructured":"Styles, C., Paschos, K., White, R., & Farrell, P. (2018). The cooperative functions of the EBNA3 proteins are central to EBV persistence and latency. Pathogens (Basel, Switzerland), 7, Article 31. https:\/\/doi.org\/10.3390\/pathogens7010031","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"1561_CR61","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1016\/j.cell.2024.06.021","volume":"187","author":"J Huang","year":"2024","unstructured":"Huang, J., Zhang, X., Nie, X., Zhang, X., Wang, Y., Huang, L., et al. (2024). Assembly and activation of EBV latent membrane protein 1. Cell, 187, 4996-5009.e14. https:\/\/doi.org\/10.1016\/j.cell.2024.06.021","journal-title":"Cell"},{"key":"1561_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.640207","volume":"11","author":"AK-F Lo","year":"2021","unstructured":"Lo, A.K.-F., Dawson, C. W., Lung, H. L., Wong, K.-L., & Young, L. S. (2021). The role of EBV-encoded LMP1 in the NPC tumor microenvironment: From function to therapy. Frontiers in Oncology, 11, Article 640207. https:\/\/doi.org\/10.3389\/fonc.2021.640207","journal-title":"Frontiers in Oncology"},{"key":"1561_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-22834-1_5","volume-title":"Epstein Barr Virus Volume 2","author":"O Cen","year":"2015","unstructured":"Cen, O., & Longnecker, R. (2015). Latent membrane protein 2 (LMP2). In C. M\u00fcnz (Ed.), Epstein Barr Virus Volume 2 (Vol. Vol. 391, pp. 151\u2013180). Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-319-22834-1_5"},{"key":"1561_CR64","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1128\/JVI.07035-11","volume":"86","author":"KHY Shair","year":"2012","unstructured":"Shair, K. H. Y., Bendt, K. M., Edwards, R. H., Nielsen, J. N., Moore, D. T., & Raab-Traub, N. (2012). Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model. Journal of Virology, 86, 5352\u20135365. https:\/\/doi.org\/10.1128\/JVI.07035-11","journal-title":"Journal of Virology"},{"key":"1561_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-5-156","volume":"5","author":"S Datta","year":"2008","unstructured":"Datta, S. (2008). An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virology Journal, 5, Article 156. https:\/\/doi.org\/10.1186\/1743-422X-5-156","journal-title":"Virology Journal"},{"key":"1561_CR66","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/JVI.02440-14","volume":"89","author":"S Rawat","year":"2015","unstructured":"Rawat, S., & Bouchard, M. J. (2015). The Hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. Journal of Virology, 89, 999\u20131012. https:\/\/doi.org\/10.1128\/JVI.02440-14","journal-title":"Journal of Virology"},{"key":"1561_CR67","doi-asserted-by":"publisher","first-page":"8255","DOI":"10.3390\/cimb45100521","volume":"45","author":"C Medina","year":"2023","unstructured":"Medina, C., Garc\u00eda, A. H., Crespo, F. I., Toro, F. I., Mayora, S. J., & De Sanctis, J. B. (2023). A synopsis of Hepatitis C virus treatments and future perspectives. Current Issues in Molecular Biology, 45, 8255\u20138276. https:\/\/doi.org\/10.3390\/cimb45100521","journal-title":"Current Issues in Molecular Biology"},{"key":"1561_CR68","unstructured":"Hepatitis C. (n.d.). Retrieved January 25, 2026, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"1561_CR69","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmi.2015.06.026","volume":"21","author":"V Schinzari","year":"2015","unstructured":"Schinzari, V., Barnaba, V., & Piconese, S. (2015). Chronic hepatitis B virus and hepatitis C virus infections and cancer: Synergy between viral and host factors. Clinical Microbiology and Infection, 21, 969\u2013974. https:\/\/doi.org\/10.1016\/j.cmi.2015.06.026","journal-title":"Clinical Microbiology and Infection"},{"key":"1561_CR70","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/cells11040741","volume":"11","author":"E Sivasudhan","year":"2022","unstructured":"Sivasudhan, E., Blake, N., Lu, Z., Meng, J., & Rong, R. (2022). Hepatitis B viral protein HBx and the molecular mechanisms modulating the hallmarks of hepatocellular carcinoma: A comprehensive review. Cells, 11, 741. https:\/\/doi.org\/10.3390\/cells11040741","journal-title":"Cells"},{"key":"1561_CR71","doi-asserted-by":"publisher","first-page":"7843","DOI":"10.1128\/JVI.77.14.7843-7855.2003","volume":"77","author":"KV Konan","year":"2003","unstructured":"Konan, K. V., Giddings, T. H., Ikeda, M., Li, K., Lemon, S. M., & Kirkegaard, K. (2003). Nonstructural protein precursor NS4A\/B from Hepatitis C virus alters function and ultrastructure of host secretory apparatus. Journal of Virology, 77, 7843\u20137855. https:\/\/doi.org\/10.1128\/JVI.77.14.7843-7855.2003","journal-title":"Journal of Virology"},{"key":"1561_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/v10100538","volume":"10","author":"A Virz\u00ec","year":"2018","unstructured":"Virz\u00ec, A., Roca Suarez, A. A., Baumert, T. F., & Lupberger, J. (2018). Oncogenic signaling induced by HCV infection. Viruses, 10, Article 538. https:\/\/doi.org\/10.3390\/v10100538","journal-title":"Viruses"},{"key":"1561_CR73","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canlet.2011.02.006","volume":"305","author":"TS Uldrick","year":"2011","unstructured":"Uldrick, T. S., & Whitby, D. (2011). Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Letters, 305, 150\u2013162. https:\/\/doi.org\/10.1016\/j.canlet.2011.02.006","journal-title":"Cancer Letters"},{"key":"1561_CR74","volume-title":"Human herpesviruses: Biology, therapy, and immunoprophylaxis","author":"PS Moore","year":"2007","unstructured":"Moore, P. S. (2007). KSHV manipulation of the cell cycle and apoptosis. Human herpesviruses: Biology, therapy, and immunoprophylaxis. Cambridge University Press."},{"key":"1561_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004154","volume":"10","author":"LE Cavallin","year":"2014","unstructured":"Cavallin, L. E., Goldschmidt-Clermont, P., & Mesri, E. A. (2014). Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi\u2019s Sarcoma associated with HIV\/AIDS. PLoS Pathogens, 10, Article e1004154. https:\/\/doi.org\/10.1371\/journal.ppat.1004154","journal-title":"PLoS Pathogens"},{"key":"1561_CR76","first-page":"485","volume":"32","author":"E Eusebio-Ponce","year":"2019","unstructured":"Eusebio-Ponce, E., Anguita, E., Paulino-Ramirez, R., & Candel, F. J. (2019). HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. Rev. Espanola Quimioter. Publicacion Of. Soc. Espanola Quimioter., 32, 485\u2013496.","journal-title":"Rev. Espanola Quimioter. Publicacion Of. Soc. Espanola Quimioter."},{"key":"1561_CR77","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3390\/v2092037","volume":"2","author":"P Kannian","year":"2010","unstructured":"Kannian, P., & Green, P. L. (2010). Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular biology and oncogenesis. Viruses, 2, 2037\u20132077. https:\/\/doi.org\/10.3390\/v2092037","journal-title":"Viruses"},{"key":"1561_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-020-0511-0","volume":"17","author":"M Matsuoka","year":"2020","unstructured":"Matsuoka, M., & Mesnard, J.-M. (2020). HTLV-1 bZIP factor: The key viral gene for pathogenesis. Retrovirology, 17, Article 2. https:\/\/doi.org\/10.1186\/s12977-020-0511-0","journal-title":"Retrovirology"},{"key":"1561_CR79","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211921","volume":"42","author":"KJ Ernzen","year":"2022","unstructured":"Ernzen, K. J., & Panfil, A. R. (2022). Regulation of HTLV-1 transformation. Bioscience Reports, 42, Article BSR20211921. https:\/\/doi.org\/10.1042\/BSR20211921","journal-title":"Bioscience Reports"},{"key":"1561_CR80","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.12998\/wjcc.v9.i19.4890","volume":"9","author":"GO Elpek","year":"2021","unstructured":"Elpek, G. O. (2021). Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World Journal of Clinical Cases, 9, 4890\u20134917. https:\/\/doi.org\/10.12998\/wjcc.v9.i19.4890","journal-title":"World Journal of Clinical Cases"},{"key":"1561_CR81","doi-asserted-by":"publisher","unstructured":"Shah, A. A., and Gupta, A. (2024). Viral cell annexation strategies: Cell surface receptor interfaces, infection, and host range. In Pathogenic Viruses and Armamentarium Design (pp. 43\u201362). Elsevier. https:\/\/doi.org\/10.1016\/B978-0-443-15241-2.00003-X","DOI":"10.1016\/B978-0-443-15241-2.00003-X"},{"key":"1561_CR82","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1098\/rstb.2011.0354","volume":"367","author":"M Woolhouse","year":"2012","unstructured":"Woolhouse, M., Scott, F., Hudson, Z., Howey, R., & Chase-Topping, M. (2012). Human viruses: Discovery and emergence. Philosophical Transactions of the Royal Society B: Biological Sciences, 367, 2864\u20132871. https:\/\/doi.org\/10.1098\/rstb.2011.0354","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences"},{"key":"1561_CR83","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41579-018-0064-6","volume":"16","author":"NA Krump","year":"2018","unstructured":"Krump, N. A., & You, J. (2018). Molecular mechanisms of viral oncogenesis in humans. Nature Reviews. Microbiology, 16, 684\u2013698. https:\/\/doi.org\/10.1038\/s41579-018-0064-6","journal-title":"Nature Reviews. Microbiology"},{"key":"1561_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-800838-6.00003-5","author":"W-S Ryu","year":"2017","unstructured":"Ryu, W.-S. (2017). Virus life cycle. Molecular Virology of Human Pathogenic Viruses. https:\/\/doi.org\/10.1016\/B978-0-12-800838-6.00003-5","journal-title":"Molecular Virology of Human Pathogenic Viruses"},{"key":"1561_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811257-1.00003-6","author":"S Rampersad","year":"2018","unstructured":"Rampersad, S., & Tennant, P. (2018). Replication and expression strategies of viruses. Viruses. https:\/\/doi.org\/10.1016\/B978-0-12-811257-1.00003-6","journal-title":"Viruses"},{"key":"1561_CR86","doi-asserted-by":"publisher","unstructured":"Villanueva, R. A., Rouill\u00e9, Y., and Dubuisson, J. (2005). Interactions Between Virus Proteins and Host Cell Membranes During the Viral Life Cycle. In International Review of Cytology (Vol. 245, pp. 171\u2013244). Elsevier. https:\/\/doi.org\/10.1016\/S0074-7696(05)45006-8","DOI":"10.1016\/S0074-7696(05)45006-8"},{"key":"1561_CR87","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1016\/j.jmb.2018.06.024","volume":"430","author":"MS Maginnis","year":"2018","unstructured":"Maginnis, M. S. (2018). Virus\u2013receptor interactions: The key to cellular invasion. Journal of Molecular Biology, 430, 2590\u20132611. https:\/\/doi.org\/10.1016\/j.jmb.2018.06.024","journal-title":"Journal of Molecular Biology"},{"key":"1561_CR88","unstructured":"Lytic vs Lysogenic \u2013 Understanding Bacteriophage Life Cycles. (n.d.). Immunology and Microbiology from Technology Networks. Retrieved January 25, 2026, from http:\/\/www.technologynetworks.com\/immunology\/articles\/lytic-vs-lysogenic-understanding-bacteriophage-life-cycles-308094"},{"key":"1561_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/v15010225","volume":"15","author":"D Gopinath","year":"2023","unstructured":"Gopinath, D., Koe, K. H., Maharajan, M. K., & Panda, S. (2023). A comprehensive overview of epidemiology, pathogenesis and the management of Herpes Labialis. Viruses, 15, Article 225. https:\/\/doi.org\/10.3390\/v15010225","journal-title":"Viruses"},{"key":"1561_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/biology14070797","volume":"14","author":"MKDS Torres","year":"2025","unstructured":"Torres, M. K. D. S., Pereira Neto, G. D. S., Cayres Vallinoto, I. M. V., Reis, L. O., & Vallinoto, A. C. R. (2025). The impact of oncogenic viruses on cancer development: A narrative review. Biology, 14, Article 797. https:\/\/doi.org\/10.3390\/biology14070797","journal-title":"Biology"},{"key":"1561_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01158","volume":"10","author":"M Koutsakos","year":"2019","unstructured":"Koutsakos, M., McWilliam, H. E. G., Aktepe, T. E., Fritzlar, S., Illing, P. T., Mifsud, N. A., et al. (2019). Downregulation of MHC Class I expression by Influenza A and B viruses. Frontiers in Immunology, 10, Article 1158. https:\/\/doi.org\/10.3389\/fimmu.2019.01158","journal-title":"Frontiers in Immunology"},{"key":"1561_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1617198","volume":"15","author":"J Bautista","year":"2025","unstructured":"Bautista, J., & Lopez-Cortes, A. (2025). Oncogenic viruses rewire the epigenome in human cancer. Frontiers in Cellular and Infection Microbiology, 15, Article 1617198. https:\/\/doi.org\/10.3389\/fcimb.2025.1617198","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"1561_CR93","unstructured":"Cooper, G. M. (2000). Tumor Suppressor Genes. In The Cell: A Molecular Approach. 2nd edition. Sinauer Associates. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK9894\/"},{"key":"1561_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1359766","volume":"14","author":"W Dong","year":"2024","unstructured":"Dong, W., Wang, H., Li, M., Li, P., & Ji, S. (2024). Virus-induced host genomic remodeling dysregulates gene expression, triggering tumorigenesis. Frontiers in Cellular and Infection Microbiology, 14, Article 1359766. https:\/\/doi.org\/10.3389\/fcimb.2024.1359766","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"1561_CR95","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146956","author":"T Enokida","year":"2021","unstructured":"Enokida, T., Moreira, A., & Bhardwaj, N. (2021). Vaccines for immunoprevention of cancer. The Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI146956","journal-title":"The Journal of Clinical Investigation"},{"key":"1561_CR96","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.21037\/jgo.2020.01.02","volume":"12","author":"R Daniel","year":"2021","unstructured":"Daniel, R., Lowry, S., & Pall, H. (2021). State of the art vaccination strategies as primary prevention to reduce incidence of gastrointestinal cancers. Journal of Gastrointestinal Oncology, 12, S316\u2013S323. https:\/\/doi.org\/10.21037\/jgo.2020.01.02","journal-title":"Journal of Gastrointestinal Oncology"},{"key":"1561_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2025.100880","volume":"43","author":"A Esmaeili","year":"2025","unstructured":"Esmaeili, A., Awasthi, P., & Tabaee, S. (2025). Beyond immortality: Epstein-Barr virus and the intricate dance of programmed cell death in cancer development. Cancer Treatment and Research Communications, 43, Article 100880. https:\/\/doi.org\/10.1016\/j.ctarc.2025.100880","journal-title":"Cancer Treatment and Research Communications"},{"key":"1561_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16003-3","volume":"11","author":"T Tomita","year":"2020","unstructured":"Tomita, T., Huibregtse, J. M., & Matouschek, A. (2020). A masked initiation region in retinoblastoma protein regulates its proteasomal degradation. Nature Communications, 11, Article 2019. https:\/\/doi.org\/10.1038\/s41467-020-16003-3","journal-title":"Nature Communications"},{"key":"1561_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010193","author":"M Celegato","year":"2021","unstructured":"Celegato, M., Messa, L., Bertagnin, C., Mercorelli, B., & Loregian, A. (2021). Targeted disruption of E6\/p53 binding exerts broad activity and synergism with Paclitaxel and Topotecan against HPV-transformed cancer cells. Cancers. https:\/\/doi.org\/10.3390\/cancers14010193","journal-title":"Cancers"},{"key":"1561_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5916-6","volume":"19","author":"J Torresi","year":"2019","unstructured":"Torresi, J., Tran, B. M., Christiansen, D., Earnest-Silveira, L., Schwab, R. H. M., & Vincan, E. (2019). HBV-related hepatocarcinogenesis: The role of signalling pathways and innovative ex vivo research models. BMC Cancer, 19, Article 707. https:\/\/doi.org\/10.1186\/s12885-019-5916-6","journal-title":"BMC Cancer"},{"key":"1561_CR101","doi-asserted-by":"publisher","DOI":"10.14218\/GE.2022.00018","author":"SS Khalid","year":"2023","unstructured":"Khalid, S. S. (2023). Disrupted regulation of host cell cycle and its clinical significance in Hepatitis C Virus-related hepatocellular carcinoma. Gene Expression. https:\/\/doi.org\/10.14218\/GE.2022.00018","journal-title":"Gene Expression"},{"key":"1561_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9070543","volume":"9","author":"S Mohanty","year":"2020","unstructured":"Mohanty, S., & Harhaj, E. W. (2020). Mechanisms of oncogenesis by HTLV-1 Tax. Pathogens, 9, Article 543. https:\/\/doi.org\/10.3390\/pathogens9070543","journal-title":"Pathogens"},{"key":"1561_CR103","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.onc.1208105","volume":"24","author":"K Kehn","year":"2005","unstructured":"Kehn, K., Fuente, C. D. L., Strouss, K., Berro, R., Jiang, H., Brady, J., et al. (2005). The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene, 24, 525\u2013540. https:\/\/doi.org\/10.1038\/sj.onc.1208105","journal-title":"Oncogene"},{"key":"1561_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01793-3","volume":"21","author":"Y Luo","year":"2021","unstructured":"Luo, Y., Liu, Y., Wang, C., & Gan, R. (2021). Signaling pathways of EBV-induced oncogenesis. Cancer Cell International, 21, Article 93. https:\/\/doi.org\/10.1186\/s12935-021-01793-3","journal-title":"Cancer Cell International"},{"key":"1561_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121261","volume":"313","author":"P Awasthi","year":"2023","unstructured":"Awasthi, P., Dwivedi, M., Kumar, D., & Hasan, S. (2023). Insights into intricacies of the latent membrane protein-1 (LMP-1) in EBV-associated cancers. Life Sciences, 313, Article 121261. https:\/\/doi.org\/10.1016\/j.lfs.2022.121261","journal-title":"Life Sciences"},{"key":"1561_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00401","author":"AP Bhatt","year":"2013","unstructured":"Bhatt, A. P., & Damania, B. (2013). AKTivation of PI3K\/AKT\/mTOR signaling pathway by KSHV. Frontiers in Immunology. https:\/\/doi.org\/10.3389\/fimmu.2012.00401","journal-title":"Frontiers in Immunology"},{"key":"1561_CR107","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.currproblcancer.2018.03.003","volume":"42","author":"S Gupta","year":"2018","unstructured":"Gupta, S., Kumar, P., & Das, B. C. (2018). HPV: Molecular pathways and targets. Current Problems in Cancer, 42, 161\u2013174. https:\/\/doi.org\/10.1016\/j.currproblcancer.2018.03.003","journal-title":"Current Problems in Cancer"},{"key":"1561_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10030262","volume":"10","author":"A Medda","year":"2021","unstructured":"Medda, A., Duca, D., & Chiocca, S. (2021). Human Papillomavirus and cellular pathways: Hits and targets. Pathogens, 10, Article 262. https:\/\/doi.org\/10.3390\/pathogens10030262","journal-title":"Pathogens"},{"key":"1561_CR109","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-virology-011720-121757","volume":"7","author":"W Liu","year":"2020","unstructured":"Liu, W., & You, J. (2020). Molecular mechanisms of Merkel Cell Polyomavirus transformation and replication. Annual Review of Virology, 7, 289\u2013307. https:\/\/doi.org\/10.1146\/annurev-virology-011720-121757","journal-title":"Annual Review of Virology"},{"key":"1561_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.739695","volume":"12","author":"NA Krump","year":"2021","unstructured":"Krump, N. A., & You, J. (2021). From Merkel Cell Polyomavirus infection to Merkel Cell Carcinoma oncogenesis. Frontiers in Microbiology, 12, Article 739695. https:\/\/doi.org\/10.3389\/fmicb.2021.739695","journal-title":"Frontiers in Microbiology"},{"key":"1561_CR111","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/curroncol30020150","volume":"30","author":"AME Elkhalifa","year":"2023","unstructured":"Elkhalifa, A. M. E., Nabi, S. U., Shah, O. S., Bashir, S. M., Muzaffer, U., Ali, S. I., et al. (2023). Insight into oncogenic viral pathways as drivers of viral cancers: Implication for effective therapy. Current Oncology, 30, 1924\u20131944. https:\/\/doi.org\/10.3390\/curroncol30020150","journal-title":"Current Oncology"},{"key":"1561_CR112","doi-asserted-by":"publisher","unstructured":"Bhaskar Kalarani, I., Thasneem, K., and Veerabathiran, R. (2023). Oncoviruses: future prospects of molecular mechanisms and therapeutic strategies. In Oncogenic Viruses (pp. 81\u2013107). Elsevier. https:\/\/doi.org\/10.1016\/B978-0-12-824156-1.00012-1","DOI":"10.1016\/B978-0-12-824156-1.00012-1"},{"key":"1561_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112761","volume":"13","author":"A Chianese","year":"2021","unstructured":"Chianese, A., Santella, B., Ambrosino, A., Stelitano, D., Rinaldi, L., Galdiero, M., et al. (2021). Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: Past, present, and future perspectives. Cancers, 13, Article 2761. https:\/\/doi.org\/10.3390\/cancers13112761","journal-title":"Cancers"},{"key":"1561_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122506","volume":"341","author":"SR Dash","year":"2024","unstructured":"Dash, S. R., Kundu, A., & Kundu, C. N. (2024). The role of viruses in cancer progression versus cancer treatment: A dual paradigm. Life Sciences, 341, Article 122506. https:\/\/doi.org\/10.1016\/j.lfs.2024.122506","journal-title":"Life Sciences"},{"key":"1561_CR115","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.micro.112408.134019","volume":"64","author":"JT Schiller","year":"2010","unstructured":"Schiller, J. T., & Lowy, D. R. (2010). Vaccines to prevent infections by oncoviruses. Annual Review of Microbiology, 64, 23\u201341. https:\/\/doi.org\/10.1146\/annurev.micro.112408.134019","journal-title":"Annual Review of Microbiology"},{"key":"1561_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/v13050822","volume":"13","author":"NAA De Almeida","year":"2021","unstructured":"De Almeida, N. A. A., Ribeiro, C. R. D. A., Raposo, J. V., & De Paula, V. S. (2021). Immunotherapy and gene therapy for oncoviruses infections: A review. Viruses, 13, Article 822. https:\/\/doi.org\/10.3390\/v13050822","journal-title":"Viruses"},{"key":"1561_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/lary.70379","author":"SR Best","year":"2026","unstructured":"Best, S. R., Friedman, A. D., Rosen, C. A., Sataloff, R. T., Matrka, L. A., & Sims, H. S. (2026). Recurrent respiratory papillomatosis foundation position statement on the management of adults with RRP. The Laryngoscope. https:\/\/doi.org\/10.1002\/lary.70379","journal-title":"The Laryngoscope"},{"key":"1561_CR118","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1823778","author":"PK Bhuyan","year":"2021","unstructured":"Bhuyan, P. K., Dallas, M., Kraynyak, K., Herring, T., Morrow, M., Boyer, J., et al. (2021). Durability of response to VGX-3100 treatment of HPV16\/18 positive cervical HSIL. Human Vaccines & Immunotherapeutics. https:\/\/doi.org\/10.1080\/21645515.2020.1823778","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"1561_CR119","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","volume":"17","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi, L., Humeau, J., Buqu\u00e9, A., Zitvogel, L., & Kroemer, G. (2020). Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews Clinical Oncology, 17, 725\u2013741. https:\/\/doi.org\/10.1038\/s41571-020-0413-z","journal-title":"Nature Reviews Clinical Oncology"},{"key":"1561_CR120","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","volume":"39","author":"EI Buchbinder","year":"2016","unstructured":"Buchbinder, E. I., & Desai, A. (2016). CTLA-4 and PD-1 pathways: Similarities, differences, and implications of their inhibition. American Journal of Clinical Oncology, 39, 98\u2013106. https:\/\/doi.org\/10.1097\/COC.0000000000000239","journal-title":"American Journal of Clinical Oncology"},{"key":"1561_CR121","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/j.seminoncol.2014.09.004","volume":"41","author":"ML Disis","year":"2014","unstructured":"Disis, M. L. (2014). Mechanism of action of immunotherapy. Seminars in Oncology, 41, S3\u2013S13. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.09.004","journal-title":"Seminars in Oncology"},{"issue":"1","key":"1561_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00617-6","volume":"12","author":"W Zhang","year":"2024","unstructured":"Zhang, W., Zeng, M., Li, Y., & Yu, L. (2024). Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies. Biomarker Research, 12(1), Article 71. https:\/\/doi.org\/10.1186\/s40364-024-00617-6","journal-title":"Biomarker Research"},{"key":"1561_CR123","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrc2966","volume":"11","author":"CV Pecot","year":"2011","unstructured":"Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G., & Sood, A. K. (2011). RNA interference in the clinic: Challenges and future directions. Nature Reviews Cancer, 11, 59\u201367. https:\/\/doi.org\/10.1038\/nrc2966","journal-title":"Nature Reviews Cancer"},{"key":"1561_CR124","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.3390\/curroncol30020152","volume":"30","author":"AA Rabaan","year":"2023","unstructured":"Rabaan, A. A., AlSaihati, H., Bukhamsin, R., Bakhrebah, M. A., Nassar, M. S., Alsaleh, A. A., et al. (2023). Application of CRISPR\/Cas9 technology in cancer treatment: A future direction. Current Oncology, 30, 1954\u20131976. https:\/\/doi.org\/10.3390\/curroncol30020152","journal-title":"Current Oncology"},{"key":"1561_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/v13050828","volume":"13","author":"M Musarra-Pizzo","year":"2021","unstructured":"Musarra-Pizzo, M., Pennisi, R., Ben-Amor, I., Mandalari, G., & Sciortino, M. T. (2021). Antiviral activity exerted by natural products against human viruses. Viruses, 13, Article 828. https:\/\/doi.org\/10.3390\/v13050828","journal-title":"Viruses"},{"key":"1561_CR126","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jep.2012.09.036","volume":"144","author":"D Manvar","year":"2012","unstructured":"Manvar, D., Mishra, M., Kumar, S., & Pandey, V. N. (2012). Identification and evaluation of anti Hepatitis C virus phytochemicals from Eclipta alba. Journal of Ethnopharmacology, 144, 545\u2013554. https:\/\/doi.org\/10.1016\/j.jep.2012.09.036","journal-title":"Journal of Ethnopharmacology"},{"key":"1561_CR127","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.biopha.2016.08.002","volume":"83","author":"S Rehman","year":"2016","unstructured":"Rehman, S., Ijaz, B., Fatima, N., Muhammad, S. A., & Riazuddin, S. (2016). Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and in silico study. Biomedicine & Pharmacotherapy, 83, 881\u2013891. https:\/\/doi.org\/10.1016\/j.biopha.2016.08.002","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"1561_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1029069","volume":"13","author":"YL Vishweshwaraiah","year":"2022","unstructured":"Vishweshwaraiah, Y. L., & Dokholyan, N. V. (2022). mRNA vaccines for cancer immunotherapy. Frontiers in Immunology, 13, Article 1029069. https:\/\/doi.org\/10.3389\/fimmu.2022.1029069","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"1561_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01082-x","volume":"31","author":"W-Y Chi","year":"2024","unstructured":"Chi, W.-Y., Hu, Y., Huang, H.-C., Kuo, H.-H., Lin, S.-H., Kuo, C.-T.J., et al. (2024). Molecular targets and strategies in the development of nucleic acid cancer vaccines: From shared to personalized antigens. Journal of Biomedical Science, 31(1), Article 94. https:\/\/doi.org\/10.1186\/s12929-024-01082-x","journal-title":"Journal of Biomedical Science"},{"key":"1561_CR130","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1128\/JVI.00239-06","volume":"80","author":"K Lan","year":"2006","unstructured":"Lan, K., Choudhuri, T., Murakami, M., Kuppers, D. A., & Robertson, E. S. (2006). Intracellular activated Notch1 is critical for proliferation of Kaposi\u2019s Sarcoma-Associated Herpesvirus-associated B-lymphoma cell lines in vitro. Journal of Virology, 80, 6411\u20136419. https:\/\/doi.org\/10.1128\/JVI.00239-06","journal-title":"Journal of Virology"},{"key":"1561_CR131","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.4161\/cbt.8.22.9743","volume":"8","author":"K Lan","year":"2009","unstructured":"Lan, K., Murakami, M., Bajaj, B., Kaul, R., He, Z., Gan, R., et al. (2009). Inhibition of KSHV infected primary effusion lymphomas in NOD\/SCID mice by \u03b3-secretase inhibitor. Cancer Biology & Therapy, 8, 2136\u20132143. https:\/\/doi.org\/10.4161\/cbt.8.22.9743","journal-title":"Cancer Biology & Therapy"},{"key":"1561_CR132","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.1074\/jbc.RA120.012645","volume":"295","author":"Q Wang","year":"2020","unstructured":"Wang, Q., Zhu, N., Hu, J., Wang, Y., Xu, J., Gu, Q., et al. (2020). The mTOR inhibitor manassantin B reveals a crucial role of mTORC2 signaling in Epstein-Barr virus reactivation. The Journal of Biological Chemistry, 295, 7431\u20137441. https:\/\/doi.org\/10.1074\/jbc.RA120.012645","journal-title":"The Journal of Biological Chemistry"},{"key":"1561_CR133","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1665-2681(19)31886-1","volume":"7","author":"N M\u00e9ndez-S\u00e1nchez;","year":"2008","unstructured":"M\u00e9ndez-S\u00e1nchez;, N., V\u00e1squez-Fern\u00e1ndez;, F., Zamora-Vald\u00e9s;, D., & Uribe, M. (2008). Sorafenib, a systemic therapy for hepatocellular carcinoma. Annals of Hepatology, 7, 46\u201351. https:\/\/doi.org\/10.1016\/S1665-2681(19)31886-1","journal-title":"Annals of Hepatology"},{"key":"1561_CR134","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv190","volume":"107","author":"S-H Wang","year":"2015","unstructured":"Wang, S.-H., Yeh, S.-H., Shiau, C.-W., Chen, K.-F., Lin, W.-H., Tsai, T.-F., et al. (2015). Sorafenib action in Hepatitis B Virus X\u2013activated oncogenic androgen pathway in liver through SHP-1. Journal of the National Cancer Institute, 107, Article djv190. https:\/\/doi.org\/10.1093\/jnci\/djv190","journal-title":"Journal of the National Cancer Institute"},{"key":"1561_CR135","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4664","author":"L Chan","year":"2018","unstructured":"Chan, L., Man, O., Kwok, H., Chen, L., Chan, K., Lung, H., et al. (2018). The Wnt modulator ICG-001 mediates the inhibition of nasopharyngeal carcinoma cell migration in vitro via the miR-150\/CD44 axis. International Journal of Oncology. https:\/\/doi.org\/10.3892\/ijo.2018.4664","journal-title":"International Journal of Oncology"},{"key":"1561_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.691644","volume":"9","author":"P Trivedi","year":"2021","unstructured":"Trivedi, P., Patel, S. K., Bellavia, D., Messina, E., Palermo, R., Ceccarelli, S., et al. (2021). When viruses cross developmental pathways. Frontiers in Cell and Developmental Biology, 9, Article 691644. https:\/\/doi.org\/10.3389\/fcell.2021.691644","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"1561_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.870316","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y., Huang, J., Jin, B., He, S., Dang, Y., Zhao, T., et al. (2022). The emerging role of Hedgehog Signaling in viral infections. Frontiers in Microbiology, 13, Article 870316. https:\/\/doi.org\/10.3389\/fmicb.2022.870316","journal-title":"Frontiers in Microbiology"},{"key":"1561_CR138","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1158\/0008-5472.CAN-12-2329","volume":"72","author":"A Arzumanyan","year":"2012","unstructured":"Arzumanyan, A., Sambandam, V., Clayton, M. M., Choi, S. S., Xie, G., Diehl, A. M., et al. (2012). Hedgehog Signaling blockade delays hepatocarcinogenesis induced by Hepatitis B Virus X Protein. Cancer Research, 72, 5912\u20135920. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2329","journal-title":"Cancer Research"},{"key":"1561_CR139","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.7150\/thno.38913","volume":"9","author":"V Kumar","year":"2019","unstructured":"Kumar, V., Dong, Y., Kumar, V., Almawash, S., & Mahato, R. I. (2019). The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis. Theranostics, 9, 7537\u20137555. https:\/\/doi.org\/10.7150\/thno.38913","journal-title":"Theranostics"},{"key":"1561_CR140","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/21645515.2020.1732166","volume":"16","author":"H Zhao","year":"2020","unstructured":"Zhao, H., Zhou, X., & Zhou, Y.-H. (2020). Hepatitis B vaccine development and implementation. Human Vaccines & Immunotherapeutics, 16, 1533\u20131544. https:\/\/doi.org\/10.1080\/21645515.2020.1732166","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"1561_CR141","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.4161\/hv.29033","volume":"10","author":"R Verma","year":"2014","unstructured":"Verma, R., Khanna, P., & Chawla, S. (2014). Hepatitis C vaccine: Need of the hour. Human Vaccines Immunother., 10, 1927\u20131929. https:\/\/doi.org\/10.4161\/hv.29033","journal-title":"Human Vaccines Immunother."},{"key":"1561_CR142","doi-asserted-by":"publisher","first-page":"e00832","DOI":"10.1128\/jvi.00832-23","volume":"97","author":"S Liu","year":"2023","unstructured":"Liu, S., Gro\u00dfkopf, A. K., Yang, X., Mannheim, M. E., Backovic, M., Scribano, S., et al. (2023). Kaposi\u2019s sarcoma-associated herpesvirus glycoprotein K8.1 is critical for infection in a cell-specific manner and functions at the attachment step on keratinocytes. Journal of Virology, 97, e00832-e923. https:\/\/doi.org\/10.1128\/jvi.00832-23","journal-title":"Journal of Virology"},{"key":"1561_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2014.27","volume":"4","author":"JI Cohen","year":"2015","unstructured":"Cohen, J. I. (2015). Epstein\u2013barr virus vaccines. Clin. Transl. Immunol., 4, Article e32. https:\/\/doi.org\/10.1038\/cti.2014.27","journal-title":"Clin. Transl. Immunol."},{"key":"1561_CR144","doi-asserted-by":"publisher","DOI":"10.22088\/IJMCM.BUMS.10.2.101","author":"M Soliman","year":"2021","unstructured":"Soliman, M., Oredein, O., & Dass, C. (2021). Update on safety and efficacy of HPV vaccines: Focus on gardasil. International Journal of Molecular and Cellular Medicine. https:\/\/doi.org\/10.22088\/IJMCM.BUMS.10.2.101","journal-title":"International Journal of Molecular and Cellular Medicine"},{"key":"1561_CR145","doi-asserted-by":"publisher","first-page":"e01623","DOI":"10.1128\/jvi.01623-23","volume":"98","author":"JJ Tu","year":"2024","unstructured":"Tu, J. J., King, E., Maksimova, V., Smith, S., Macias, R., Cheng, X., et al. (2024). An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits. Journal of Virology, 98, e01623-e1723. https:\/\/doi.org\/10.1128\/jvi.01623-23","journal-title":"Journal of Virology"},{"key":"1561_CR146","doi-asserted-by":"publisher","first-page":"105730","DOI":"10.1016\/j.phrs.2021.105730","volume":"170","author":"J Sadri Nahand","year":"2021","unstructured":"Sadri Nahand, J., Rabiei, N., Fathazam, R., Taghizadieh, M., Ebrahimi, M. S., Mahjoubin-Tehran, et al. (2021). Oncogenic viruses and chemoresistance: What do we know? Pharmacological Research, 170, 105730. https:\/\/doi.org\/10.1016\/j.phrs.2021.105730","journal-title":"Pharmacological Research"},{"key":"1561_CR147","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.chom.2010.06.014","volume":"8","author":"SH Speck","year":"2010","unstructured":"Speck, S. H., & Ganem, D. (2010). Viral latency and its regulation: Lessons from the \u03b3-Herpesviruses. Cell Host & Microbe, 8, 100\u2013115. https:\/\/doi.org\/10.1016\/j.chom.2010.06.014","journal-title":"Cell Host & Microbe"},{"key":"1561_CR148","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.tim.2018.08.011","volume":"27","author":"N Saranathan","year":"2019","unstructured":"Saranathan, N., & Vivekanandan, P. (2019). G-Quadruplexes: More than just a kink in microbial genomes. Trends in Microbiology, 27, 148\u2013163. https:\/\/doi.org\/10.1016\/j.tim.2018.08.011","journal-title":"Trends in Microbiology"},{"key":"1561_CR149","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0078","volume":"28","author":"A Vasukutty","year":"2024","unstructured":"Vasukutty, A., Jang, Y., Han, D., Park, H., & Park, I.-K. (2024). Navigating latency-inducing viral infections: Therapeutic targeting and nanoparticle utilization. Biomaterials Research, 28, Article 0078. https:\/\/doi.org\/10.34133\/bmr.0078","journal-title":"Biomaterials Research"},{"key":"1561_CR150","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s40588-024-00230-z","volume":"11","author":"M Chen","year":"2024","unstructured":"Chen, M., Li, Y., Qin, Q., Yang, L., Jiang, M., Xin, Y., et al. (2024). Update on the regulation and maintenance of Epstein-Barr virus latency. Current Clinical Microbiology Reports, 11, 200\u2013207. https:\/\/doi.org\/10.1007\/s40588-024-00230-z","journal-title":"Current Clinical Microbiology Reports"},{"key":"1561_CR151","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S2055-6640(20)30275-2","volume":"5","author":"J Vanhamel","year":"2019","unstructured":"Vanhamel, J., Bruggemans, A., & Debyser, Z. (2019). Establishment of latent HIV-1 reservoirs: What do we really know? Journal of Virus Eradication, 5, 3\u20139. https:\/\/doi.org\/10.1016\/S2055-6640(20)30275-2","journal-title":"Journal of Virus Eradication"},{"key":"1561_CR152","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12935-024-03510-2","volume":"24","author":"Y Tian","year":"2024","unstructured":"Tian, Y., Wang, X., Wu, C., Qiao, J., Jin, H., & Li, H. (2024). A protracted war against cancer drug resistance. Cancer Cell International, 24, 326. https:\/\/doi.org\/10.1186\/s12935-024-03510-2","journal-title":"Cancer Cell International"},{"key":"1561_CR153","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","volume":"22","author":"SU Khan","year":"2024","unstructured":"Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024). Unveiling the mechanisms and challenges of cancer drug resistance. Cell Communication and Signaling: CCS, 22, 109. https:\/\/doi.org\/10.1186\/s12964-023-01302-1","journal-title":"Cell Communication and Signaling: CCS"},{"key":"1561_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/v17050599","volume":"17","author":"N Narsana","year":"2025","unstructured":"Narsana, N., Ha, D., & Ho, D. Y. (2025). Treating Adenovirus infection in transplant populations: Therapeutic options beyond Cidofovir? Viruses, 17, Article 599. https:\/\/doi.org\/10.3390\/v17050599","journal-title":"Viruses"},{"key":"1561_CR155","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1128\/AAC.04348-14","volume":"59","author":"AE Caruso Brown","year":"2015","unstructured":"Caruso Brown, A. E., Cohen, M. N., Tong, S., Braverman, R. S., Rooney, J. F., Giller, R., et al. (2015). Pharmacokinetics and safety of intravenous Cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. Antimicrobial Agents and Chemotherapy, 59, 3718\u20133725. https:\/\/doi.org\/10.1128\/AAC.04348-14","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"1561_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13092462","volume":"13","author":"M Poppens","year":"2024","unstructured":"Poppens, M., Ruci, A., & Davis, J. (2024). Cutaneous applications of the antiviral drug Cidofovir: A review. Journal of Clinical Medicine, 13, Article 2462. https:\/\/doi.org\/10.3390\/jcm13092462","journal-title":"Journal of Clinical Medicine"},{"key":"1561_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.904790","volume":"12","author":"PS Aghbash","year":"2022","unstructured":"Aghbash, P. S., Hemmat, N., Fathi, H., & Baghi, H. B. (2022). Monoclonal antibodies in cervical malignancy-related HPV. Frontiers in Oncology, 12, Article 904790. https:\/\/doi.org\/10.3389\/fonc.2022.904790","journal-title":"Frontiers in Oncology"},{"key":"1561_CR158","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S1286-4579(00)01329-0","volume":"2","author":"DR Taylor","year":"2000","unstructured":"Taylor, D. R., Shi, S. T., & Lai, M. M. C. (2000). Hepatitis C virus and interferon resistance. Microbes and Infection, 2, 1743\u20131756. https:\/\/doi.org\/10.1016\/S1286-4579(00)01329-0","journal-title":"Microbes and Infection"},{"key":"1561_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10060197","volume":"10","author":"JS Pagano","year":"2018","unstructured":"Pagano, J. S., Whitehurst, C. B., & Andrei, G. (2018). Antiviral drugs for EBV. Cancers, 10, Article 197. https:\/\/doi.org\/10.3390\/cancers10060197","journal-title":"Cancers"},{"key":"1561_CR160","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s11864-013-0231-y","volume":"14","author":"JA Kanakry","year":"2013","unstructured":"Kanakry, J. A., & Ambinder, R. F. (2013). EBV-related lymphomas: New approaches to treatment. Current Treatment Options in Oncology, 14, 224\u2013236. https:\/\/doi.org\/10.1007\/s11864-013-0231-y","journal-title":"Current Treatment Options in Oncology"},{"key":"1561_CR161","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/COH.0b013e328322402e","volume":"4","author":"DR Kuritzkes","year":"2009","unstructured":"Kuritzkes, D. R. (2009). HIV-1 entry inhibitors: An overview: Current Opinion in HIV and AIDS, 4, 82\u201387. https:\/\/doi.org\/10.1097\/COH.0b013e328322402e","journal-title":"Current Opinion in HIV and AIDS"},{"key":"1561_CR162","doi-asserted-by":"publisher","unstructured":"Mohan, L. (2021). Plant-Based Drugs as an Adjuvant to Cancer Chemotherapy. In M. Akram (Ed.), Alternative Medicine - Update. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.94040","DOI":"10.5772\/intechopen.94040"},{"issue":"9","key":"1561_CR163","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X241282923","volume":"19","author":"G Atampugbire","year":"2024","unstructured":"Atampugbire, G., Adomako, E. E. A., & Quaye, O. (2024). Medicinal plants as effective antiviral agents and their potential benefits. Natural Product Communications, 19(9), Article 1934578X241282923. https:\/\/doi.org\/10.1177\/1934578X241282923","journal-title":"Natural Product Communications"},{"key":"1561_CR164","doi-asserted-by":"publisher","first-page":"43302","DOI":"10.1021\/acsomega.4c07756","volume":"9","author":"C Sanjai","year":"2024","unstructured":"Sanjai, C., Gaonkar, S. L., & Hakkimane, S. S. (2024). Harnessing Nature\u2019s toolbox: Naturally derived bioactive compounds in nanotechnology enhanced formulations. ACS Omega, 9, 43302\u201343318. https:\/\/doi.org\/10.1021\/acsomega.4c07756","journal-title":"ACS Omega"},{"key":"1561_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/cells14221753","volume":"14","author":"GSVSR Reddy","year":"2025","unstructured":"Reddy, G. S. V. S. R., Nandy, S. K., Cherukuri, P., Samanta, K., & Kar, P. (2025). Ayurvedic phytochemicals in oncology: ADP-ribosylation as a molecular nexus. Cells, 14, Article 1753. https:\/\/doi.org\/10.3390\/cells14221753","journal-title":"Cells"},{"key":"1561_CR166","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2174\/18715206113139990078","volume":"13","author":"A Ahmad","year":"2013","unstructured":"Ahmad, A., Biersack, B., Li, Y., Kong, D., Bao, B., Schobert, R., et al. (2013). Targeted regulation of PI3K\/Akt\/mTOR\/NF-\u03baB signaling by indole compounds and their derivatives: Mechanistic details and biological implications for cancer therapy. Anti-Cancer Agents in Medicinal Chemistry, 13, 1002\u20131013. https:\/\/doi.org\/10.2174\/18715206113139990078","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"key":"1561_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1070367","volume":"13","author":"S Bernitsa","year":"2023","unstructured":"Bernitsa, S., Dayan, R., Stephanou, A., Tzvetanova, I. D., & Patrikios, I. S. (2023). Natural biomolecules and derivatives as anticancer immunomodulatory agents. Frontiers in Immunology, 13, Article 1070367. https:\/\/doi.org\/10.3389\/fimmu.2022.1070367","journal-title":"Frontiers in Immunology"},{"key":"1561_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00352-w","volume":"6","author":"J Li","year":"2025","unstructured":"Li, J., Hu, J., Yang, Y., Zhang, H., Liu, Y., Fang, Y., et al. (2025). Drug resistance in cancer: Molecular mechanisms and emerging treatment strategies. Mol. Biomed., 6, Article 111. https:\/\/doi.org\/10.1186\/s43556-025-00352-w","journal-title":"Mol. Biomed."},{"key":"1561_CR169","doi-asserted-by":"publisher","DOI":"10.1080\/20523211.2025.2574651","volume":"18","author":"MAA Khan","year":"2025","unstructured":"Khan, M. A. A., Khalid, M., & Malik, O. (2025). The safety of herbal medicines in low- and middle-income countries (LMICs): Current landscape and promoting the pharmacovigilance practices. Journal of Pharmaceutical Policy and Practice, 18, Article 2574651. https:\/\/doi.org\/10.1080\/20523211.2025.2574651","journal-title":"Journal of Pharmaceutical Policy and Practice"},{"key":"1561_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081291","volume":"10","author":"M Sharma","year":"2021","unstructured":"Sharma, M., Dhaliwal, I., Rana, K., Delta, A., & Kaushik, P. (2021). Phytochemistry, pharmacology, and toxicology of Datura species\u2014a review. Antioxidants, 10, Article 1291. https:\/\/doi.org\/10.3390\/antiox10081291","journal-title":"Antioxidants"},{"key":"1561_CR171","doi-asserted-by":"publisher","unstructured":"Acute poisoning due to ingestion of Datura stramonium \u2013 a case report. (2017). Romanian Romanian J. Anaesth. Intensive Care . https:\/\/doi.org\/10.21454\/rjaic.7518.241.szb","DOI":"10.21454\/rjaic.7518.241.szb"},{"key":"1561_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040885","volume":"14","author":"K O\u2019Brien","year":"2022","unstructured":"O\u2019Brien, K. (2022). Cannabidiol (CBD) in cancer management. Cancers, 14, Article 885. https:\/\/doi.org\/10.3390\/cancers14040885","journal-title":"Cancers"},{"key":"1561_CR173","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/0974-8490.199780","volume":"9","author":"HC Lowe","year":"2017","unstructured":"Lowe, H. C., Toyang, N., & McLaughlin, W. (2017). Potential of cannabidiol for the treatment of viral hepatitis. Pharmacognosy Research, 9, 116. https:\/\/doi.org\/10.4103\/0974-8490.199780","journal-title":"Pharmacognosy Research"},{"key":"1561_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-2-34","volume":"2","author":"MM Medveczky","year":"2004","unstructured":"Medveczky, M. M., Sherwood, T. A., Klein, T. W., Friedman, H., & Medveczky, P. G. (2004). Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro. BMC Medicine, 2, Article 34. https:\/\/doi.org\/10.1186\/1741-7015-2-34","journal-title":"BMC Medicine"},{"key":"1561_CR175","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2022-0068","volume":"9","author":"S Monika","year":"2023","unstructured":"Monika, S., Thirumal, M., & Kumar, P. (2023). Phytochemical and biological review of Aegle marmelos Linn. Future Science OA, 9, Article FSO849. https:\/\/doi.org\/10.2144\/fsoa-2022-0068","journal-title":"Future Science OA"},{"key":"1561_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/nano12091530","volume":"12","author":"R Goyal","year":"2022","unstructured":"Goyal, R., Bala, R., Sindhu, R. K., Zehravi, M., Madaan, R., Ramproshad, S., et al. (2022). Bioactive based nanocarriers for the treatment of viral infections and SARS-CoV-2. Nanomaterials, 12, Article 1530. https:\/\/doi.org\/10.3390\/nano12091530","journal-title":"Nanomaterials"},{"issue":"sup1","key":"1561_CR177","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/01635581.2013.785008","volume":"65","author":"S Mahata","year":"2013","unstructured":"Mahata, S., Pandey, A., Shukla, S., Tyagi, A., Husain, S. A., Das, B. C., et al. (2013). Anticancer activity of Phyllanthus emblica Linn. (Indian Gooseberry): Inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells. Nutrition and Cancer, 65(sup1), 88\u201397. https:\/\/doi.org\/10.1080\/01635581.2013.785008","journal-title":"Nutrition and Cancer"},{"key":"1561_CR178","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.22207\/JPAM.13.4.11","volume":"13","author":"SK Khurana","year":"2019","unstructured":"Khurana, S. K., Tiwari, R., Sharun, K., Yatoo, M. I., Gugjoo, M. B., & Dhama, K. (2019). Emblica officinalis (Amla) with a particular focus on its antimicrobial potentials: A review. Journal of Pure and Applied Microbiology, 13, 1995\u20132012. https:\/\/doi.org\/10.22207\/JPAM.13.4.11","journal-title":"Journal of Pure and Applied Microbiology"},{"key":"1561_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16706","volume":"9","author":"LJ Bou Malhab","year":"2023","unstructured":"Bou Malhab, L. J., Bajbouj, K., Shehab, N. G., Elayoty, S. M., Sinoj, J., Adra, S., et al. (2023). Potential anticancer properties of Calotropis procera: An investigation on breast and colon cancer cells. Heliyon, 9, Article e16706. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16706","journal-title":"Heliyon"},{"key":"1561_CR180","doi-asserted-by":"publisher","DOI":"10.53555\/AJBR.v27i4S.5557","author":"S Awasthi","year":"2024","unstructured":"Awasthi, S. (2024). Prosopis cineraria: A Multifaceted Tree: From cultural significance to medicinal potential. African Journal of Biomedical Research. https:\/\/doi.org\/10.53555\/AJBR.v27i4S.5557","journal-title":"African Journal of Biomedical Research"},{"key":"1561_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/ph17070818","volume":"17","author":"C Singai","year":"2024","unstructured":"Singai, C., Pitchakarn, P., Taya, S., Phannasorn, W., Wongpoomchai, R., & Wongnoppavich, A. (2024). Chemopreventive potential of Phyllanthus emblica fruit extract against colon and liver cancer using a dual-organ rat carcinogenesis model. Pharmaceuticals, 17, Article 818. https:\/\/doi.org\/10.3390\/ph17070818","journal-title":"Pharmaceuticals"},{"key":"1561_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2023.100106","volume":"4","author":"T Islam","year":"2023","unstructured":"Islam, T., Ara, I., Islam, T., Sah, P. K., Almeida, R. S. D., Matias, E. F. F., et al. (2023). Ethnobotanical uses and phytochemical, biological, and toxicological profiles of Datura metel L.: A review. Current Research in Toxicology, 4, Article 100106. https:\/\/doi.org\/10.1016\/j.crtox.2023.100106","journal-title":"Current Research in Toxicology"},{"key":"1561_CR183","doi-asserted-by":"publisher","DOI":"10.3390\/app11062864","volume":"11","author":"M Al-Zharani","year":"2021","unstructured":"Al-Zharani, M., Nasr, F. A., Alqahtani, A. S., Cordero, M. A. W., Alotaibi, A. A., Bepari, A., et al. (2021). In vitro cytotoxic evaluation and apoptotic effects of Datura innoxia grown in Saudi Arabia and phytochemical analysis. Applied Sciences, 11, Article 2864. https:\/\/doi.org\/10.3390\/app11062864","journal-title":"Applied Sciences"},{"key":"1561_CR184","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/1947601912466556","volume":"3","author":"Y Maor","year":"2012","unstructured":"Maor, Y., Yu, J., Kuzontkoski, P. M., Dezube, B. J., Zhang, X., & Groopman, J. E. (2012). Cannabidiol inhibits growth and induces programmed cell death in Kaposi Sarcoma-Associated Herpesvirus-infected endothelium. Genes & Cancer, 3, 512\u2013520. https:\/\/doi.org\/10.1177\/1947601912466556","journal-title":"Genes & Cancer"},{"key":"1561_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/biology11060817","volume":"11","author":"CG Heider","year":"2022","unstructured":"Heider, C. G., Itenberg, S. A., Rao, J., Ma, H., & Wu, X. (2022). Mechanisms of cannabidiol (CBD) in cancer treatment: A review. Biology, 11, Article 817. https:\/\/doi.org\/10.3390\/biology11060817","journal-title":"Biology"},{"key":"1561_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s40816-021-00289-x","volume":"7","author":"AM Olajuyin","year":"2021","unstructured":"Olajuyin, A. M., Olajuyin, A. K., Wang, Z., Zhao, X., Xu, Z., Zhang, Q., et al. (2021). Anti-proliferative, antioxidant effects of methanol extract of Calotropis procera leaf on lung cancer cells (H1299) and its ameliorative effect on expression of CD146 on blood cells. Clinical Phytoscience, 7, Article 51. https:\/\/doi.org\/10.1186\/s40816-021-00289-x","journal-title":"Clinical Phytoscience"},{"key":"1561_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-81037-2","volume":"14","author":"M Naveed","year":"2024","unstructured":"Naveed, M., Hussain, M., Aziz, T., Hanif, N., Kanwal, N., Arshad, A., et al. (2024). Computational biology assisted exploration of phytochemicals derived natural inhibitors to block BZLF1 gene activation of Epstein\u2013Bar virus in host. Scientific Reports, 14, Article 31664. https:\/\/doi.org\/10.1038\/s41598-024-81037-2","journal-title":"Scientific Reports"},{"key":"1561_CR188","doi-asserted-by":"publisher","DOI":"10.47070\/ayushdhara.v10i1.1143","author":"Yamini and Sr Singara Subramanian","year":"2023","unstructured":"Yamini and Sr Singara Subramanian. (2023). Extraction of Prosopis Cineraria from Bikaner, Rajasthan of India- Detection of Compounds via GCMS, Calibration via HPLC, UV, FTIR, FESEM EDAX- An Anti-Cancer Agent For Blood Cancer with Validated IC50 via Testing Over Country Eggs. Ayushdhara. https:\/\/doi.org\/10.47070\/ayushdhara.v10i1.1143","journal-title":"Ayushdhara"},{"key":"1561_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00912","volume":"10","author":"D Praditya","year":"2019","unstructured":"Praditya, D., Kirchhoff, L., Br\u00fcning, J., Rachmawati, H., Steinmann, J., & Steinmann, E. (2019). Anti-infective properties of the golden spice curcumin. Frontiers in Microbiology, 10, Article 912. https:\/\/doi.org\/10.3389\/fmicb.2019.00912","journal-title":"Frontiers in Microbiology"},{"key":"1561_CR190","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.antiviral.2019.04.011","volume":"167","author":"H Li","year":"2019","unstructured":"Li, H., Zhong, C., Wang, Q., Chen, W., & Yuan, Y. (2019). Curcumin is an APE1 redox inhibitor and exhibits an antiviral activity against KSHV replication and pathogenesis. Antiviral Research, 167, 98\u2013103. https:\/\/doi.org\/10.1016\/j.antiviral.2019.04.011","journal-title":"Antiviral Research"},{"key":"1561_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01236","volume":"9","author":"E Guven-Maiorov","year":"2019","unstructured":"Guven-Maiorov, E., Tsai, C.-J., & Nussinov, R. (2019). Oncoviruses can drive cancer by rewiring signaling pathways through interface mimicry. Frontiers in Oncology, 9, Article 1236.","journal-title":"Frontiers in Oncology"},{"key":"1561_CR192","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/jcm6120111","volume":"6","author":"UN Mui","year":"2017","unstructured":"Mui, U. N., Haley, C. T., & Tyring, S. K. (2017). Viral oncology: Molecular biology and pathogenesis. Journal of Clinical Medicine, 6, 111.","journal-title":"Journal of Clinical Medicine"},{"key":"1561_CR193","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02198-8","volume":"16","author":"A Zafar","year":"2025","unstructured":"Zafar, A., Khatoon, S., Khan, M. J., Abu, J., & Naeem, A. (2025). Advancements and limitations in traditional anti-cancer therapies: A comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discover Oncology, 16, Article 607. https:\/\/doi.org\/10.1007\/s12672-025-02198-8","journal-title":"Discover Oncology"},{"issue":"10","key":"1561_CR194","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.13040\/IJPSR.0975-8232.6.4103-12","volume":"6","author":"M Greenwell","year":"2015","unstructured":"Greenwell, M., & Rahman, P. K. S. M. (2015). Medicinal plants: Their use in anticancer treatment. International Journal of Pharmaceutical Sciences and Research, 6(10), 4103\u20134112. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.6.4103-12","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"key":"1561_CR195","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering12010007","author":"GM Hashim","year":"2024","unstructured":"Hashim, G. M., Shahgolzari, M., Hefferon, K., Yavari, A., & Venkataraman, S. (2024). Plant-derived anti-cancer therapeutics and biopharmaceuticals. Bioengineering (Basel, Switzerland). https:\/\/doi.org\/10.3390\/bioengineering12010007","journal-title":"Bioengineering (Basel, Switzerland)"},{"key":"1561_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01614","volume":"10","author":"AS Choudhari","year":"2020","unstructured":"Choudhari, A. S., Mandave, P. C., Deshpande, M., Ranjekar, P., & Prakash, O. (2020). Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Frontiers in Pharmacology, 10, Article 1614. https:\/\/doi.org\/10.3389\/fphar.2019.01614","journal-title":"Frontiers in Pharmacology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-026-01561-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:02:31Z","timestamp":1781820151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-026-01561-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":196,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1007\/s12033-026-01561-6","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}